Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome - PubMed (original) (raw)
Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome
B Termanini et al. Am J Med. 1998 May.
Abstract
Background and aims: Long-term treatment with H(+)-K(+)-adenotriphosphatase (ATPase) inhibitors, such as omeprazole or lansoprazole, for severe gastroesophageal reflux disease is now widely used. Whether such treatment will result in vitamin B12 deficiency is controversial. We studied whether long-term treatment with omeprazole alters serum vitamin B12 levels in patients with Zollinger-Ellison syndrome.
Methods: In 131 consecutive patients treated with either omeprazole (n = 111) or histamine H2-receptor antagonists (n = 20), serum vitamin B12 and folate levels and complete blood counts were determined after acid secretion had been controlled for at least 6 months. These studies were repeated yearly. Serum vitamin B12 and folate levels were correlated with the type of antisecretory drug and the extent of inhibition of acid secretion.
Results: The mean duration of omeprazole treatment was 4.5 years, and for H2-receptor antagonists 10 years. Vitamin B12 levels, but not serum folate levels or any hematological parameter, were significantly (P = 0.03) lower in patients treated with omeprazole, especially those with omeprazole-induced sustained hyposecretion (P = 0.0014) or complete achlorhydria (P < 0.0001). In 68 patients with two determinations at least 5 years apart, vitamin B12 levels decreased significantly (30%; P = 0.001) only in patients rendered achlorhydric. The duration of omeprazole treatment was inversely correlated with vitamin B12 levels (P = 0.013), but not folate levels. Eight patients (6%) developed subnormal B12 levels during follow-up.
Conclusions: Long-term omeprazole treatment leads to significant decreases in serum vitamin B12 but not folate levels. These results suggest patients with Zollinger-Ellison syndrome treated with H(+)-K(+)-ATPase inhibitors should have serum vitamin B12 levels monitored. Furthermore, these results raise the possibility that other patients treated chronically with H(+)-K(+)-ATPase inhibitors may develop B12 deficiency.
Similar articles
- Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy.
Stewart CA, Termanini B, Sutliff VE, Serrano J, Yu F, Gibril F, Jensen RT. Stewart CA, et al. Aliment Pharmacol Ther. 1998 Jan;12(1):83-98. doi: 10.1046/j.1365-2036.1998.00274.x. Aliment Pharmacol Ther. 1998. PMID: 9692706 Clinical Trial. - Treatment of patients with Zollinger-Ellison syndrome.
Mignon M, Pospai D, Forestier S, Vatier J, Vallot T. Mignon M, et al. Clin Ther. 1993;15 Suppl B:22-31. Clin Ther. 1993. PMID: 8205592 Review. - Development of sustained achlorhydria in a patient with the Zollinger-Ellison syndrome treated with omeprazole.
Griffith JL, Cummings OW, Hirschowitz BI. Griffith JL, et al. Gastroenterology. 1991 Jul;101(1):242-6. doi: 10.1016/0016-5085(91)90484-3. Gastroenterology. 1991. PMID: 1796940 - Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.
Metz DC, Pisegna JR, Ringham GL, Feigenbaum K, Koviack PD, Maton PN, Gardner JD, Jensen RT. Metz DC, et al. Dig Dis Sci. 1993 Feb;38(2):245-56. doi: 10.1007/BF01307541. Dig Dis Sci. 1993. PMID: 8425437 Free PMC article. Clinical Trial.
Cited by
- Long-Term Proton Pump Inhibitor-Acid Suppressive Treatment Can Cause Vitamin B12 Deficiency in Zollinger-Ellison Syndrome (ZES) Patients.
Ito T, Ramos-Alvarez I, Jensen RT. Ito T, et al. Int J Mol Sci. 2024 Jul 2;25(13):7286. doi: 10.3390/ijms25137286. Int J Mol Sci. 2024. PMID: 39000391 Free PMC article. - Prospective Randomized Controlled Clinical Trial of the Long-Term Effects of Omeprazole on Healthy Dogs.
Gil-Vicente L, Martín G, Soler C, Vila A, Saiz MR, Navarro PF. Gil-Vicente L, et al. Animals (Basel). 2024 Apr 12;14(8):1168. doi: 10.3390/ani14081168. Animals (Basel). 2024. PMID: 38672316 Free PMC article. - Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study.
Losurdo G, Caccavo NLB, Indellicati G, Celiberto F, Ierardi E, Barone M, Di Leo A. Losurdo G, et al. J Clin Med. 2023 Apr 17;12(8):2910. doi: 10.3390/jcm12082910. J Clin Med. 2023. PMID: 37109245 Free PMC article. - Association of Vitamin B12 deficiency with long-term PPIs use: A cohort study.
Mumtaz H, Ghafoor B, Saghir H, Tariq M, Dahar K, Ali SH, Waheed ST, Syed AA. Mumtaz H, et al. Ann Med Surg (Lond). 2022 Sep 26;82:104762. doi: 10.1016/j.amsu.2022.104762. eCollection 2022 Oct. Ann Med Surg (Lond). 2022. PMID: 36268318 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources